Skip to content
A friend to farmers and champion of the biotech sector, Sen. Debbie Stabenow announced last week she won’t run for a fifth term in […]
Sen. Debbie Stabenow, a biotech champion, won’t run for a fifth term in 2024 Read More »
According to a new study from the American Cancer Society Cancer published Thursday, cancer deaths in the United States have decreased by 33% over
Cancer deaths down 33% in three decades, new study shows Read More »
As researchers raced to identify new COVID-19 subvariants, worldwide capacity for genomic sequencing increased, enabling the application of the process for other public health
Boosted by COVID, genomic sequencing gains traction globally Read More »
The 41st J.P. Morgan Healthcare Conference is taking place in San Francisco this week, and the Biotechnology Innovation Organization (BIO) has been helping attendees
J.P. Morgan health event brings big deals; BIO platform boosts partnering Read More »
In 2022 drug manufacturers actually charged less for their products and patients paid slightly more than the previous year—but the cost of prescription medicines
While net drug prices drop, patients pay more thanks to health plans and PBMs Read More »
Biopharmaceutical company Ocugen announced its COVID-19 vaccine candidate Covaxin, developed by Bharat Biotech, showed positive results in the U.S. trial. Ocugen, a Biotechnology Innovation
Ocugen’s vaccine candidate Covaxin met both co-primary endpoints in study Read More »
As U.S. President Joe Biden attends the North American Leaders’ Summit in Mexico, the Biotechnology Innovation Organization (BIO) and a number of organizations involved
USMCA has trade rules – let’s stick to them, says BIO Read More »
Dalan Animal Health, a U.S. biotech company pioneering insect health, announced last week that the U.S. Department of Agriculture (USDA) has given a conditional
USDA greenlights first-in-class honeybee vaccine Read More »
One positive outcome of the COVID-19 pandemic is the advancement of mRNA technology, which is on track to help us create the next wave
Is mRNA technology the new standard in vaccine-making? Read More »
The U.S. Food and Drug Administration (FDA) on Friday granted accelerated approval for the Alzheimer’s drug LEQEMBI (lecanemab-irmb). The drug is developed by two biotech
FDA grants accelerated approval for Eisai’s new Alzheimer’s drug Read More »
